Senior insider sale
SVP & PAO at ASCENDIS PHARMA A/S — senior position signals high conviction
$1.66M
6.87K shares
What this filing means
BODENHOFF MADS plans to sell 6.87K shares of ASCENDIS PHARMA A/S valued at approximately $1.66M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001973379-26-000061
Officer· SVP & PAO
Since Mar 2026
6.87K
Shares to sell
$1.66M
Approx. market value
6.87K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RESTRICTED STOCK VESTING
COMPENSATION
3/2/2026
6.87KTotal acquired6.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | RESTRICTED STOCK VESTING COMPENSATION | 6.87K | — |
| Total | 6.87K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.87K
Market value
$1.66M
3/2/2026
Total
Units
6.87K
Value
$1.66M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/2/2026 | 6.87K | $1.66M | NASDAQ | Planned |
| Total | 6.87K | $1.66M | ||